Evaluation of three antimicrobial regimens used as metaphylaxis in stocker calves at high risk of developing bovine respiratory disease

Vet Ther. 2007 Summer;8(2):136-47.

Abstract

A total of 894 calves at high risk for bovine respiratory disease were processed at two sites and randomly assigned to receive one of three antimicrobial metaphylactic regimens to determine if a two-drug regimen offered any advantage over the more conventional one-course regimens. On arrival, calves received either a two-course regimen of ceftiofur crystalline free acid (CCFA) followed by tulathromycin 8 days later (Group 1) or a one-course regiment of CCFA (Group 2) or tilmicosin (Group 3). At Site A, morbidity was significantly lower (52%) in Group 1 than in Group 2 (76.3%) and Group 3 (78.4%). At Site B, morbidity was significantly lower in Group 1 (2.6%) than in Group 2 (9.4%) and Group 3 (7.2%).

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Bovine Respiratory Disease Complex / mortality
  • Bovine Respiratory Disease Complex / prevention & control*
  • Cattle
  • Cephalosporins / therapeutic use*
  • Disaccharides / therapeutic use*
  • Drug Therapy, Combination
  • Heterocyclic Compounds / therapeutic use*
  • Male
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Disaccharides
  • Heterocyclic Compounds
  • ceftiofur
  • tulathromycin